Idaho Attorney General Raúl Labrador has secured a $29.6 million settlement with pharmaceutical company Glenmark tied to allegations of a drug price conspiracy, the attorney general’s office announced.

The settlement represents one of the larger pharmaceutical enforcement actions involving Idaho in recent years. Drug pricing conspiracies typically involve agreements among manufacturers or distributors to artificially inflate prices paid by consumers, insurers, and government health programs.

Labrador’s office did not release additional details in the initial announcement regarding which drugs were involved, the scope of the alleged conspiracy, or how settlement funds would be distributed.

The resolution adds to a broader pattern of state attorneys general pursuing pharmaceutical companies over pricing practices that drive up costs for Idaho residents and public health programs. Further details on fund allocation are expected as the settlement moves through final approval.